Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2024.03.29
白熊生物：董事会审计委员会对会计师事务所2023年度履行监督职责情况报告
2024.03.29
白熊生物：董事会关于2023年度内部控制审计报告带强调事项段的无保留审计意见涉及事项的专项说明
2024.03.29
白熊生物：董事会对独立董事独立性评估的专项意见
2024.03.29
白熊生物：2023年度内部控制评价报告
2024.03.29
白熊生物：2023年度监事会工作报告
2023.12.18
白熊生物：公司章程
2023.11.21
公司章程
2021.12.11
独立董事关于第五届董事会第十五次会议相关事项的独立意见
2021.10.16
独立董事关于第五届董事会第十二次会议相关事项的独立意见
2021.08.27
公司章程（2021年8月）
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
